See also this year's filing and all EDGAR filings for this company.
PDF Report 0001693011_2023_Inozyme_Pharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001693011, Inozyme Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 131,393,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,018,000 |
| 3 | remainder_Assets | 5,784,000 |
| 4 | LiabilitiesCurrent | 14,715,000 |
| 5 | LiabilitiesNoncurrent | 1,947,000 |
| 6 | remainder_Liabilities | 4,139,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,826,000 |
| 9 | ResearchAndDevelopmentExpense | 47,849,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,614,000 |
| 13 | remainder_ComprehensiveNetIncome | -223,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 139,195,000 |
| 1 | Liabilities | 20,801,000 |
| 2 | Expenses | 68,675,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 118,394,000 |
| 5 | NetIncome | -67,061,000 |
| 6 | ComprehensiveNetIncome | -67,172,500 |
| 7 | BaseVar | 115,254,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.39 |
| 9 | EconomicCapitalRatio | 3.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
